Letrozole is generally the best first medicine for helping people with polycystic ovary syndrome (PCOS) ovulate when difficulty ovulating is the main reason they are not getting pregnant. It usually works better than clomiphene for ovulation and live birth in this situation. The right choice still depends on your health, other fertility factors, local approval, and a clinician’s assessment of your situation.
Why Is Letrozole Usually the Best Ovulation Medicine for PCOS?
PCOS can interfere with the regular release of eggs from the ovaries. When ovulation happens infrequently or does not happen at all, becoming pregnant can be more difficult. Letrozole is an oral medicine that helps stimulate ovulation, giving an egg an opportunity to be released for fertilization.
The 2023 international evidence-based guideline for PCOS, published through the American Society for Reproductive Medicine (ASRM), recommends letrozole as the first-choice medication for ovulation induction in people with PCOS who have difficulty ovulating and no other identified infertility factors. Compared with clomiphene citrate, letrozole is recommended because it improves ovulation, clinical pregnancy, and live birth outcomes in this group.
However, letrozole is not automatically the best option for every person with PCOS. Its suitability depends on whether irregular ovulation is the main fertility problem, whether other factors affect the chance of pregnancy, and whether the medicine is appropriate and permitted for this use in the person's country.
Which Medicines Can Help With Ovulation in PCOS?
Several medicines may be considered when PCOS affects ovulation. They do not work in exactly the same way, and they are not equally effective for every purpose. Letrozole is usually preferred for ovulation induction, while other medicines may be considered when letrozole is unsuitable, unavailable, or unsuccessful.
1. Letrozole: The usual first choice
Letrozole is an oral medicine that temporarily changes estrogen production and encourages the hormonal signals involved in egg development. A healthcare professional prescribes the dose and timing based on the treatment plan. The aim is to support the development and release of an egg so that pregnancy can occur naturally or with another fertility treatment if needed.
One important practical point is that letrozole is used off-label for ovulation induction in many countries. This means its use for fertility treatment may not be specifically included in the medicine's approved indications, even though clinical guidelines recommend it for appropriate patients with PCOS. A fertility specialist can explain its evidence, local regulatory status, possible side effects, and alternatives before treatment begins.
2. Clomiphene citrate: An alternative oral medicine
Clomiphene citrate, sometimes known by the brand name Clomid, is another medicine that stimulates ovulation. It may be considered when letrozole cannot be used or is not available. Although clomiphene can help the ovaries release an egg, current international guidance generally favors letrozole for people with PCOS-related anovulatory infertility when no other fertility factors have been identified.
The U.S. National Library of Medicine's MedlinePlus explains that clomiphene can cause effects such as hot flushes, stomach discomfort, and visual changes. It also increases the chance of a multiple pregnancy, such as twins. Any visual disturbance or significant abdominal symptoms during treatment should be reported promptly to the prescribing clinician.
3. Metformin: Useful in selected situations
Metformin is primarily used to improve the body's response to insulin and help manage blood sugar. Because metabolic and hormonal factors can be involved in PCOS, it may also help some people ovulate more regularly. A clinician may consider it when metabolic concerns are present or as part of an individualized fertility plan.
Metformin is not generally the most effective medicine when the main goal is to induce ovulation. The international PCOS guideline notes that it may be used alone in selected cases of anovulatory infertility, but more effective ovulation-induction medicines are available. It may also be combined with clomiphene in certain circumstances. Common side effects include nausea, diarrhea, and other gastrointestinal symptoms.
4. Injectable gonadotropins: An option when tablets are unsuccessful
Gonadotropins are hormone medicines given by injection to stimulate ovarian follicle development. They may be considered when oral ovulation medicines have not worked. Because they can stimulate several follicles at once, they require closer monitoring than many oral treatment plans and carry a greater risk of multiple pregnancy. Excessive ovarian response can also lead to ovarian hyperstimulation syndrome, a condition involving enlarged ovaries and fluid shifts within the body.
The American College of Obstetricians and Gynecologists (ACOG) explains that ovulation-stimulating medicines may require blood tests and ultrasound examinations to monitor the ovaries and help reduce treatment risks. Injectable medicines are therefore usually managed by a fertility specialist rather than used without supervision.
How Does a Doctor Decide Which Ovulation Medicine Is Right?
The choice starts with understanding whether ovulation problems are actually the main obstacle to pregnancy. A healthcare professional will review menstrual patterns, reproductive and medical history, current medicines, and other relevant findings. Irregular or absent periods may suggest that ovulation is not occurring regularly, but the overall clinical picture helps determine the next steps.
Other fertility factors also matter. Evaluation may include checking ovulation, assessing the uterus and whether the fallopian tubes are open, and testing a male partner's semen when relevant. These checks help identify problems that ovulation medicine alone cannot correct. The American Society for Reproductive Medicine's fertility-evaluation guidance recommends an assessment that considers both partners and the relevant reproductive factors rather than focusing only on egg release.
The treatment plan may also depend on previous responses to fertility medicine, possible medication interactions, side effects, personal preferences, and the availability of monitoring. If another fertility factor is present, the most useful approach may involve additional treatment rather than simply increasing the dose of an ovulation medicine.
What Should You Expect During Ovulation Treatment?
Before starting treatment, the clinician will determine whether pregnancy could already be present and whether additional assessment is needed. The medicine is then prescribed according to an individualized plan. The exact dose, timing, and length of treatment vary, so a regimen that was prescribed for another person should not be copied.
Monitoring helps determine whether treatment is producing the intended response. Depending on the medicine and the clinical situation, this may involve menstrual-cycle tracking, blood tests to assess hormone levels, ultrasound scans to observe follicle development, or other checks recommended by the fertility team. Monitoring can also help identify an excessive response that may increase the chance of multiple pregnancy.
Ovulation and pregnancy are different outcomes. A medicine may help an egg be released without guaranteeing fertilization or pregnancy. The outcome also depends on other factors, including sperm health, the fallopian tubes, and the reproductive environment. If ovulation does not occur or pregnancy does not follow, the clinician can review the response and decide whether to adjust the plan or consider another option.
Is Letrozole Safe for People Trying to Get Pregnant?
Letrozole should not be taken when there is a possibility of an existing pregnancy. The National Health Service (NHS) advises that letrozole is not recommended during pregnancy because its hormonal effects may affect the developing baby. The prescribing clinician should explain when treatment can begin and whether pregnancy testing is needed before a treatment cycle.
Letrozole and other ovulation medicines should be used under appropriate medical supervision. Your clinician can discuss expected benefits, possible adverse effects, and whether the proposed use is approved or off-label in your location. Do not use leftover fertility medicines, change the prescribed dose, combine ovulation drugs, or repeat treatment cycles without guidance.
Clomiphene and injectable gonadotropins also have important safety considerations, especially the possibility of multiple pregnancy. The type and level of monitoring needed depend on the medicine and how the ovaries respond. Seek prompt medical assessment if you develop significant abdominal pain or swelling, difficulty breathing, or other concerning symptoms during fertility treatment.
What Happens If Letrozole Does Not Work?
If letrozole does not lead to ovulation or pregnancy, the next step is not necessarily to switch medicines immediately. The fertility specialist may review the diagnosis, confirm how the ovaries responded, check whether another fertility factor needs attention, and discuss the benefits and risks of changing the treatment plan.
Depending on the findings, options may include another oral medicine, a combination of medicines, injectable gonadotropins with close monitoring, or assisted reproductive treatment such as in vitro fertilization (IVF). These approaches are not needed by everyone. The goal is to select the least complex suitable treatment that addresses the identified fertility problem while considering safety, personal preferences, and the likelihood of success.
When Should You Seek Fertility Advice?
Consider an appointment with a gynecologist or fertility specialist if menstrual cycles are consistently irregular or absent and you are planning a pregnancy, or if you have been trying to conceive without success. You do not always need to wait a full year when a known condition may affect fertility. Age also matters: general guidance recommends fertility evaluation after 12 months of trying for people younger than 35, after 6 months for those aged 35 or older, and more immediate assessment for those over 40. Known ovulation problems may warrant earlier evaluation.
Before the appointment, it may help to record menstrual dates, list current medicines and supplements, and bring results from any previous fertility tests. These details can help the clinician determine whether letrozole is appropriate or whether another treatment better fits your circumstances.